Stories
Nvidia To Invest In French Medical Platform Doctolib
- •AI chip giant Nvidia will take a minority stake in the French medical website Doctolib to improve healthcare technology.
- •Doctolib allows patients to book doctor appointments and store medical information for easy record sharing.
- •The company launched an AI research program in August to study data from its 50 million users and improve healthcare navigation.
- •Doctolib will use Nvidia chips to develop its own in-house AI models for personal assistants and administrative tasks, keeping control over patient data.
- •Doctolib was valued at 3.6 billion euros during its most recent funding round earlier this year.
Key Questions Answered
Nvidia plans to take a minority stake in the French medical website Doctolib to help improve health care using artificial intelligence. While the exact investment amount was not disclosed, Nvidia's chief executive noted that the company invested at least $8 billion in Europe last year.
Doctolib will use Nvidia chips to power its in-house AI models and personal assistants for patients and doctors, helping with administrative tasks and improving navigation of the healthcare system. This approach allows Doctolib to retain control over its AI models and patient data instead of relying on proprietary external models.
Doctolib was valued at 3.6 billion euros, which equals about $4.0 billion, during its funding round earlier this year. The private platform currently serves 50 million users for booking doctor appointments and storing medical records.
